Tiger Brokers

  • Quotes
  • Products
    • Cash Boost Account
    • US Stocks
    • US Fractional Shares
    • HK Stocks
    • China A-shares
    • Options
    • Futures
    • US Treasury
    • Auto-invest
    • Fixed Coupon Notes
    • Tiger BOSS Debit Card
    • Fund Mall
    • Tiger Vault
    • Tiger Open Platform
    • Wealth
  • Pricing
    • Prime
      • Stocks & ETFs
      • Options, Warrants & CBBCs
      • Futures
      • Bonds
      • Fund Mall
    • Cash Boost
      • Stocks & ETFs
    • Financing Interest Rates
  • Promotions
  • Help
    • Account Operations
      • How to Open an Account?
      • Account Opening Documents
      • Account Types Available
    • Transfer & Pay
      • Account Funding
      • DDA Fast Deposit
      • Funds Withdrawal
      • Shares Transfer-in
      • Shares Transfer-out
      • Currency Conversion
    • Products & Trading
      • Products Available
      • Order Types
      • Trading Rules
      • Declaration
    • Margin Trading & Short Selling
      • Margin & Leverage
      • Risk Management
      • Short Selling Risk
    • Fund Mall
      • Open a fund account and transaction
    • Cash Boost Account
      • Cash Boost Account FAQ
      • How to Open Cash Boost Account
      • How to Contra Trade using Cash Boost Account
      • How to link your CDP Securities Account
    • Tiger Boss Debit Card
      • Frequently Asked Questions
      • Fees of the Debit card
      • How to Top-up
      • How to use my Debit card
    • Tiger Vault
      • Features of Tiger Vault
      • Transaction Fees
    • Statement
      • Statement
      • Dividends
  • Learn
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
  • Careers
    • L.E.A.P Programme
    • Investment Representative
    • Careers Portal
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Organon & Co

10.04
+0.28002.87%
Post-market: 10.060.0200+0.20%17:32 EDT
Volume:5.10M
Turnover:51.39M
Market Cap:2.61B
PE:3.49
High:10.24
Open:9.82
Low:9.72
Close:9.76
Loading ...
OverviewCompanyNewsFilings

Organon transferred with a Hold at TD Cowen

TIPRANKS
·
15 Jan

FDA approves Organon’s VTAMA cream, 1% for the treatment for AD

TipRanks
·
17 Dec 2024

Organon Says Vtama Cream Approved by FDA for Atopic Dermatitis

MT Newswires Live
·
16 Dec 2024

BRIEF-FDA Approves Vtama® Cream, 1% For The Treatment Of Atopic Dermatitis

Reuters
·
16 Dec 2024

FDA Approves Vtama® (Tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older

THOMSON REUTERS
·
16 Dec 2024

BRIEF-FDA Approves Dermavant Science's Vtama For Topical Treatment Of Atopic Dermatitis In Adult & Pediatric Patients 2 Years & Older

Reuters
·
14 Dec 2024

FDA: Approves Dermavant Science's Vtama for Topical Treatment of Atopic Dermatitis in Adult & Pediatric Patients 2 Years & Older - Website

THOMSON REUTERS
·
14 Dec 2024

Earnings Working Against Organon & Co.'s (NYSE:OGN) Share Price

Simply Wall St.
·
13 Dec 2024

Analyst Rate

Hold
Buy
37.50%
Hold
25.00%
Sell
37.50%

Corporate Actions

Ex-dividend Date
May 12, 2025 Dividend Per Share 0.02 USD
Financial Report Announcement
May 01, 2025 Pre-Market
Ex-dividend Date
Feb 24, 2025 Dividend Per Share 0.28 USD
Financial Report Announcement
Feb 13, 2025 Pre-Market
Ex-dividend Date
Nov 12, 2024 Dividend Per Share 0.28 USD

Dividend History

Ex-DateDividend
2021-08-200.28
2021-11-190.28
2022-02-250.28
2022-05-130.28
2022-08-120.28

Valuation Analysis

3.31
Current
5.50
Sector Average
9.41%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
3.31
Maximum
8.07
+1 STD
6.83
Minimum
2.89
-1 STD
4.17
Average
5.50

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.